C12Y 204/01068
Glycoprotein 6-alpha-l-fucosyltransferase , i.e. fut8
Official title: Glycoprotein 6-alpha-L-fucosyltransferase (2.4.1.68), i.e. FUT8
C12Y204/01068 (Glycoprotein 6-alpha-l-fucosyltransferase , i.e. fut8) appears on 27 US grants and 49 published applications in this corpus.
Search patents in C12Y- Granted patents
- 27
- Published applications
- 49
- Assignees
- 19
- Inventors
- 116
- Latest grant
- 20 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 4 |
| 2007 | 0 | 2 |
| 2008 | 2 | 2 |
| 2009 | 0 | 4 |
| 2010 | 3 | 4 |
| 2011 | 3 | 5 |
| 2012 | 4 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 2 | 1 |
| 2018 | 0 | 2 |
| 2019 | 2 | 3 |
| 2020 | 1 | 2 |
| 2021 | 1 | 4 |
| 2022 | 3 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant chimeric protein for selectins targeting20 Feb 2024US 11,905,323 B2Bracco Suisse SA
- DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof10 Jan 2023US 11,548,937 B2Zumutor Biologics Inc.
- Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof22 Nov 2022US 11,505,609 B2Bio-Thera Solutions, Ltd.
- Recombinant chimeric protein for selectins targeting28 Jun 2022US 11,370,826 B2Bracco Suisse SA
- Afucosylated protein, cell expressing said protein and associated methods8 Mar 2022US 11,267,899 B2Zumutor Biologics Inc.
- Antibody against hepatitis b virus, preparation thereof and use thereof27 Aug 2026US 2026/0250361 A1Huahui Health Ltd.
- Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products5 Oct 2023US 2023/0313187 A1Dna Twopointo Inc.
- Recombinant antibody having unique glycan profile produced by cho host cell with edited genome and preparation method thereof29 Jun 2023US 2023/0203169 A1Bio-Thera Solutions, Ltd.
- Recombinant chimeric protein for selectins targeting8 Dec 2022US 2022/0389080 A1Bracco Suisse SA
- Biosynthetic glycoprotein populations10 Nov 2022US 2022/0356266 A1Janssen Biotech, Inc.
Most cited
By later US patents
- Cells producing antibody compositions with increased antibody dependent cytotoxic activity247US 6,946,292 B2Kyowa Hakko Kogyo Co., Ltd. · 2005
- Antibody composition-producing cell51US 7,425,446 B2Kyowa Hakko Kogyo Co., Ltd. · 2008
- Antibody composition-producing cell38US 7,737,325 B2Kyowa Hakko Kirin Co., Ltd. · 2010
- Methods and compositions for producing double allele knock outs28US 9,663,782 B2Larix Bioscience, LLC · 2017
- Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase27US 7,393,683 B2Kyowa Hakko Kogyo Co., Ltd. · 2008